Global Glycosylated Biosimilars Market Research Report 2019

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 99

Report ID: 24474

Glycosylated Biosimilars include mA, EPO etc in this report.

The global Glycosylated Biosimilars market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Glycosylated Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glycosylated Biosimilars market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG

Segment by Regions
North America
Europe
China
Japan

Segment by Type
mAb
EPO

Segment by Application
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases

Table of Contents

Executive Summary
1 Glycosylated Biosimilars Market Overview
1.1 Product Overview and Scope of Glycosylated Biosimilars
1.2 Glycosylated Biosimilars Segment by Type
1.2.1 Global Glycosylated Biosimilars Production Growth Rate Comparison by Type (2014-2025)
1.2.2 mAb
1.2.3 EPO
1.3 Glycosylated Biosimilars Segment by Application
1.3.1 Glycosylated Biosimilars Consumption Comparison by Application (2014-2025)
1.3.2 Oncology
1.3.3 Chronic Diseases
1.3.4 Autoimmune Diseases
1.3.5 Blood Disorders
1.3.6 Growth Hormone Deficiency
1.3.7 Infectious Diseases
1.3.8 Other Diseases
1.4 Global Glycosylated Biosimilars Market by Region
1.4.1 Global Glycosylated Biosimilars Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Glycosylated Biosimilars Market Size
1.5.1 Global Glycosylated Biosimilars Revenue (2014-2025)
1.5.2 Global Glycosylated Biosimilars Production (2014-2025)

2 Global Glycosylated Biosimilars Market Competition by Manufacturers
2.1 Global Glycosylated Biosimilars Production Market Share by Manufacturers (2014-2019)
2.2 Global Glycosylated Biosimilars Revenue Share by Manufacturers (2014-2019)
2.3 Global Glycosylated Biosimilars Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Glycosylated Biosimilars Production Sites, Area Served, Product Types
2.5 Glycosylated Biosimilars Market Competitive Situation and Trends
2.5.1 Glycosylated Biosimilars Market Concentration Rate
2.5.2 Glycosylated Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Glycosylated Biosimilars Production Market Share by Regions
3.1 Global Glycosylated Biosimilars Production Market Share by Regions
3.2 Global Glycosylated Biosimilars Revenue Market Share by Regions (2014-2019)
3.3 Global Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Glycosylated Biosimilars Production
3.4.1 North America Glycosylated Biosimilars Production Growth Rate (2014-2019)
3.4.2 North America Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Glycosylated Biosimilars Production
3.5.1 Europe Glycosylated Biosimilars Production Growth Rate (2014-2019)
3.5.2 Europe Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Glycosylated Biosimilars Production (2014-2019)
3.6.1 China Glycosylated Biosimilars Production Growth Rate (2014-2019)
3.6.2 China Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Glycosylated Biosimilars Production (2014-2019)
3.7.1 Japan Glycosylated Biosimilars Production Growth Rate (2014-2019)
3.7.2 Japan Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Glycosylated Biosimilars Consumption by Regions
4.1 Global Glycosylated Biosimilars Consumption by Regions
4.2 North America Glycosylated Biosimilars Consumption (2014-2019)
4.3 Europe Glycosylated Biosimilars Consumption (2014-2019)
4.4 China Glycosylated Biosimilars Consumption (2014-2019)
4.5 Japan Glycosylated Biosimilars Consumption (2014-2019)

5 Global Glycosylated Biosimilars Production, Revenue, Price Trend by Type
5.1 Global Glycosylated Biosimilars Production Market Share by Type (2014-2019)
5.2 Global Glycosylated Biosimilars Revenue Market Share by Type (2014-2019)
5.3 Global Glycosylated Biosimilars Price by Type (2014-2019)
5.4 Global Glycosylated Biosimilars Production Growth by Type (2014-2019)

6 Global Glycosylated Biosimilars Market Analysis by Applications
6.1 Global Glycosylated Biosimilars Consumption Market Share by Application (2014-2019)
6.2 Global Glycosylated Biosimilars Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Glycosylated Biosimilars Business
7.1 Sandoz
7.1.1 Sandoz Glycosylated Biosimilars Production Sites and Area Served
7.1.2 Glycosylated Biosimilars Product Introduction, Application and Specification
7.1.3 Sandoz Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Pfizer
7.2.1 Pfizer Glycosylated Biosimilars Production Sites and Area Served
7.2.2 Glycosylated Biosimilars Product Introduction, Application and Specification
7.2.3 Pfizer Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Teva Pahrmaceutical
7.3.1 Teva Pahrmaceutical Glycosylated Biosimilars Production Sites and Area Served
7.3.2 Glycosylated Biosimilars Product Introduction, Application and Specification
7.3.3 Teva Pahrmaceutical Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Celltrion
7.4.1 Celltrion Glycosylated Biosimilars Production Sites and Area Served
7.4.2 Glycosylated Biosimilars Product Introduction, Application and Specification
7.4.3 Celltrion Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Biocon
7.5.1 Biocon Glycosylated Biosimilars Production Sites and Area Served
7.5.2 Glycosylated Biosimilars Product Introduction, Application and Specification
7.5.3 Biocon Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Amgen
7.6.1 Amgen Glycosylated Biosimilars Production Sites and Area Served
7.6.2 Glycosylated Biosimilars Product Introduction, Application and Specification
7.6.3 Amgen Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Samsung Biologics
7.7.1 Samsung Biologics Glycosylated Biosimilars Production Sites and Area Served
7.7.2 Glycosylated Biosimilars Product Introduction, Application and Specification
7.7.3 Samsung Biologics Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Mylan
7.8.1 Mylan Glycosylated Biosimilars Production Sites and Area Served
7.8.2 Glycosylated Biosimilars Product Introduction, Application and Specification
7.8.3 Mylan Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Dr. Reddy's Laboratories
7.9.1 Dr. Reddy's Laboratories Glycosylated Biosimilars Production Sites and Area Served
7.9.2 Glycosylated Biosimilars Product Introduction, Application and Specification
7.9.3 Dr. Reddy's Laboratories Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Stada Arzneimittel AG
7.10.1 Stada Arzneimittel AG Glycosylated Biosimilars Production Sites and Area Served
7.10.2 Glycosylated Biosimilars Product Introduction, Application and Specification
7.10.3 Stada Arzneimittel AG Glycosylated Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served

8 Glycosylated Biosimilars Manufacturing Cost Analysis
8.1 Glycosylated Biosimilars Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Glycosylated Biosimilars
8.4 Glycosylated Biosimilars Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Glycosylated Biosimilars Distributors List
9.3 Glycosylated Biosimilars Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Glycosylated Biosimilars Market Forecast
11.1 Global Glycosylated Biosimilars Production, Revenue Forecast
11.1.1 Global Glycosylated Biosimilars Production Growth Rate Forecast (2019-2025)
11.1.2 Global Glycosylated Biosimilars Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Glycosylated Biosimilars Price and Trend Forecast (2019-2025)
11.2 Global Glycosylated Biosimilars Production Forecast by Regions (2019-2025)
11.2.1 North America Glycosylated Biosimilars Production, Revenue Forecast (2019-2025)
11.2.2 Europe Glycosylated Biosimilars Production, Revenue Forecast (2019-2025)
11.2.3 China Glycosylated Biosimilars Production, Revenue Forecast (2019-2025)
11.2.4 Japan Glycosylated Biosimilars Production, Revenue Forecast (2019-2025)
11.3 Global Glycosylated Biosimilars Consumption Forecast by Regions (2019-2025)
11.3.1 North America Glycosylated Biosimilars Consumption Forecast (2019-2025)
11.3.2 Europe Glycosylated Biosimilars Consumption Forecast (2019-2025)
11.3.3 China Glycosylated Biosimilars Consumption Forecast (2019-2025)
11.3.4 Japan Glycosylated Biosimilars Consumption Forecast (2019-2025)
11.4 Global Glycosylated Biosimilars Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Glycosylated Biosimilars Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer